Vanguard Capital Management Acquires 7.51% Stake in Pfizer Inc

On May 1, 2026, Vanguard Capital Management LLC filed a Schedule 13G with the SEC, reporting a significant new ownership stake in Pfizer Inc (PFE). As of the event date on March 31, 2026, Vanguard disclosed beneficial ownership of 427,444,872 shares of Pfizer's common stock, representing a 7.51% ownership interest in the company. This filing marks a substantial increase from a previous ownership level of 0.0%. The filing indicates that Vanguard exercises sole dispositive power over all 427,444,872 shares, while holding sole voting power over 58,014,860 shares. The securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. This position includes holdings by various Vanguard affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. No other single person's interest in the reported securities exceeds 5%. This move establishes Vanguard as a major institutional shareholder in the pharmaceutical giant.